Latent myofascial trigger point injection improves symptoms in functional gastrointestinal disorders

Table 2 Rapid symptom relief effect of latent myofascial trigger point injection therapy, mean ± SD

Symptom indicators	Baseline	2 weeks	4 weeks	P value
GSRS score
Injection group	14.2 ± 3.5	8.7 ± 2.4	6.3 ± 1.9	< 0.01
Medication group	14.5 ± 3.6	11.3 ± 3.1	9.6 ± 2.7	< 0.01
IBS-SSS score
Injection group	12.6 ± 3.2	7.5 ± 2.1	5.4 ± 1.7	< 0.01
Medication group	12.8 ± 3.5	10.2 ± 2.8	8.7 ± 2.5	< 0.01
Abdominal pain intensity
Injection group	6.3 ± 1.7	3.5 ± 1.2	2.1 ± 0.9	< 0.01
Medication group	6.5 ± 1.8	4.8 ± 1.5	3.7 ± 1.3	< 0.01
Bloating severity
Injection group	5.7 ± 1.5	3.2 ± 1.1	2.0 ± 0.8	< 0.01
Medication group	5.9 ± 1.6	4.5 ± 1.3	3.5 ± 1.2	< 0.01
Abnormal defecation
Injection group	4.8 ± 1.3	2.7 ± 0.9	1.6 ± 0.7	< 0.01
Medication group	5.0 ± 1.4	3.9 ± 1.2	2.8 ± 1.0	< 0.01

GSRS: Gastrointestinal Symptom Rating Scale; IBS-SSS: Irritable Bowel Syndrome Severity Scoring System.